SecProbe.io

Filing text and metadata
Intelligence Terminal Search Probe Scores Topics IPO Watchlist Monthly Activity About API

SEC Comment Letter for Cryoport, Inc. (CYRX) (CIK 0001124524) (CYRX) — Sep 14, 2016

Cryoport, Inc. (CYRX) (CIK 0001124524)
Date: Sept. 14, 2016 · CIK: 0001124524 · Accession: 0000000000-16-092720

AI Filing Summary & Sentiment

Sentiment
Urgency
Document Type
Confidence
SEC Posture
Company Posture

Summary

Reasoning

Date
August 30, 2016
Author
/s/ Perry J. Hindin
Form
UPLOAD
Company
Cryoport, Inc. (CYRX) (CIK 0001124524)

Letter

September 1 3, 2016 Via E -mail Robert Stefanovich Chief Financial Officer 17305 Daimler Street Irvine, CA 92614 Registration Statement on Form S -4 File No. 333 -213091 Filed August 30, 2016

Re: Cryoport, Inc. Schedule TO -I File No. 005 -85385

Dear Mr. Stefanovich :

We have reviewed the above filings and have the following comment .

General

1. We note your response to prior comment 3 and are unable to agree with your conclusion that “the Offer will not cause th e Original Warrants to cease being listed on the NASDAQ Capital Market” given that the exchange offer is an offer for all outstanding Original Warrants. Please provide further analysis explaining the basis upon which you have concluded that the purchase o f this class of securities is not sub ject to Exchange Act Rule 13e -3.

* * *

Please contact Justin A. Kisner, Staff Attorney, at (202) 551 -3788, or me at (202) 551 - 3444 with any questions.

Sincerely,
/s/ Perry J. Hindin

Show Raw Text
September 1 3, 2016

Via E -mail
Robert Stefanovich
Chief Financial Officer
17305 Daimler Street
Irvine, CA 92614

Re: Cryoport, Inc.
Schedule TO -I
File No. 005 -85385

Registration Statement on Form S -4
File No. 333 -213091
Filed August 30, 2016

Dear Mr. Stefanovich :

We have reviewed the above  filings  and have the following comment .

General

1. We note your response to prior comment 3 and are unable to agree with your conclusion
that “the Offer will not cause th e Original Warrants to cease being listed on the
NASDAQ Capital Market” given that the exchange offer is an offer for all outstanding
Original Warrants.  Please provide further analysis explaining the basis upon which you
have concluded that the purchase o f this class of securities is not sub ject to Exchange Act
Rule 13e -3.

*     *     *

Please contact Justin A. Kisner, Staff Attorney, at (202) 551 -3788, or me at (202) 551 -
3444 with any questions.

Sincerely,

/s/ Perry J. Hindin

Perry J. Hindin
Specia l Counsel
Office of Mergers and Acquisitions

Mr. Robert Stefanovich
Cryoport, Inc.
September 13 , 2016
Page 2

 cc: Via E -mail
 Anthony Ippolito, Esq.
 Snell & Wilmer L.L.P.